MedTrace Logo

Hemospec Device for the Diagnosis of Sepsis

NCT03306186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2018-05-15

No results posted yet for this study

Summary

A diagnostic devise, namely HemoSpec, had been developed that integrates clinical information, along with information on circulating protein biomarkers and the morphology of white blood cells to achieve early diagnosis of sepsis. The current study is aiming to validate and improve performance of HemoSpec for the rapid assessment of the critically ill patient.

Conditions

Interventions

DEVICE

HemoSpec

Blood sampling for analysis

Sponsors & Collaborators

  • Ippokration General Hospital

    collaborator OTHER

  • Tzanion General Hospital of Piraeus

    collaborator UNKNOWN

  • Aghia Olga Konstantopouleion General Hospital

    collaborator UNKNOWN

  • University of Athens

    lead OTHER

Principal Investigators

  • Evangelos J Giamarellos-Bourboulis, MD, PhD · National and Kapodistrian University of Athens

  • Konstantinos Toutouzas, MD, PhD · National and Kapodistrian University of Athens

  • Athanasios Prekates, MD, PhD · Tzaneion General Hospital

  • Stylianos Karatzas, MD, PhD · Ippokration General Hospital

  • Christos Mathas, MD · Aghia Olga General Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-09
Primary Completion
2017-12-30
Completion
2018-03-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306186 on ClinicalTrials.gov